StemCell Institute Inc. (TYO:7096)
Japan · Delayed Price · Currency is JPY 748.00
-1.00 (-0.13%)
Sep 16, 2026, 3:30 PM JST
StemCell Institute Market Cap
StemCell Institute has a market cap or net worth of 7.54 billion as of September 15, 2026. Its market cap has decreased by -23.00% in one year.
Market Cap
7.54B
Enterprise Value
5.84B
Revenue
2.81B
Ranking
n/a
PE Ratio
48.80
Stock Price
748.00
ChartMarket Cap Chart
Since June 25, 2021, StemCell Institute's market cap has decreased from 21.16B to 7.54B, a decrease of -64.35%. That is a compound annual growth rate of -17.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 7.54B | -5.55% |
| Dec 30, 2025 | 7.99B | -39.54% |
| Dec 30, 2024 | 13.21B | -39.88% |
| Dec 29, 2023 | 21.97B | -17.47% |
| Dec 30, 2022 | 26.62B | 9.16% |
| Dec 30, 2021 | 24.39B | 15.25% |
| Jun 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Carna Biosciences | 9.03B |
| Nano Holdings | 8.94B |
| CellSeed | 8.75B |
| J-Pharma | 8.40B |
| Kidswell Bio | 8.25B |
| BrightPath Biotherapeutics | 7.92B |
| ADR Biomedical Holdings | 7.44B |
| SUSMED,Inc. | 6.84B |